Prenetics Global Ltd (PRE)
4.68
-0.29
(-5.84%)
USD |
NASDAQ |
Apr 26, 14:51
Prenetics Global Enterprise Value: -3.836M for April 25, 2024
Enterprise Value Chart
Historical Enterprise Value Data
Date | Value |
---|---|
April 25, 2024 | -3.836M |
April 24, 2024 | -6.033M |
April 23, 2024 | -8.718M |
April 22, 2024 | -19.58M |
April 19, 2024 | -29.10M |
April 18, 2024 | -25.56M |
April 17, 2024 | -26.05M |
April 16, 2024 | -25.32M |
April 15, 2024 | -21.90M |
April 12, 2024 | -19.09M |
April 11, 2024 | -17.90M |
April 10, 2024 | -15.80M |
April 09, 2024 | -14.82M |
April 08, 2024 | -18.36M |
April 05, 2024 | -20.19M |
April 04, 2024 | -21.66M |
April 03, 2024 | -20.07M |
April 02, 2024 | -19.09M |
April 01, 2024 | -12.99M |
March 28, 2024 | -15.06M |
March 27, 2024 | -20.92M |
March 26, 2024 | -21.05M |
March 25, 2024 | -9.573M |
March 22, 2024 | -7.010M |
March 21, 2024 | -7.193M |
Date | Value |
---|---|
March 20, 2024 | -7.132M |
March 19, 2024 | -8.23M |
March 18, 2024 | -8.840M |
March 15, 2024 | -7.376M |
March 14, 2024 | -7.132M |
March 13, 2024 | -5.423M |
March 12, 2024 | -3.348M |
March 11, 2024 | -1.395M |
March 08, 2024 | 4.708M |
March 07, 2024 | -2.860M |
March 06, 2024 | -4.324M |
March 05, 2024 | -3.714M |
March 04, 2024 | -3.226M |
March 01, 2024 | -5.179M |
February 29, 2024 | -4.202M |
February 28, 2024 | -5.179M |
February 27, 2024 | -5.301M |
February 26, 2024 | -4.324M |
February 23, 2024 | -4.080M |
February 22, 2024 | -4.080M |
February 21, 2024 | -2.982M |
February 20, 2024 | -1.822M |
February 16, 2024 | -1.151M |
February 15, 2024 | -2.096M |
February 14, 2024 | -2.250M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
-105.01M
Minimum
Aug 24 2023
816.83M
Maximum
May 18 2022
71.84M
Average
-3.592M
Median
Feb 02 2024
Enterprise Value Benchmarks
RadNet Inc | 4.271B |
DermTech Inc | -35.60M |
Centogene NV | -- |
iSpecimen Inc | -2.459M |
23andMe Holding Co | -20.76M |
Enterprise Value Related Metrics
Net Income (Quarterly) | -13.57M |
Revenue (Quarterly) | 4.866M |
Total Expenses (Quarterly) | 19.64M |
EPS Diluted (Quarterly) | -1.20 |
Gross Profit Margin (Quarterly) | 33.37% |
Profit Margin (Quarterly) | -278.9% |
Earnings Yield | -89.74% |
Operating Earnings Yield | 46.51% |
Normalized Earnings Yield | 212.13 |